We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

121 hedge funds and large institutions have $248M invested in Rigel Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more call options, than puts

Call options by funds: $115K | Put options by funds: $35K

58% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 31

26% more capital invested

Capital invested by funds: $197M → $248M (+$50.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 122 → 121 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

Holders
121
Holders Change
-1
Holders Change %
-0.82%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
49
Reduced
31
Closed
10
Calls
$115K
Puts
$35K
Net Calls
+$80K
Net Calls Change
+$61K

Top Buyers

1
RSCM
Rock Springs Capital Management
Maryland
+$3.34M
2
BFA
BlackRock Fund Advisors
California
+$3.33M
3
PC
Paulson & Co
New York
+$1.6M
4
Millennium Management
Millennium Management
New York
+$1.12M
5
ACP
Acuta Capital Partners
California
+$776K

Top Sellers

1
BC
Broadfin Capital
New York
-$6.06M
2
TC
TFS Capital
Pennsylvania
-$843K
3
UBS AM
UBS AM
Illinois
-$634K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$619K
5
MOACM
Mutual of America Capital Management
New York
-$422K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$40.2M +$9.85K +325 +0%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$18.4M +$651K +21,465 +4%
PAI
3
Palo Alto Investors
California
$15.9M +$190K +6,280 +1%
O
4
OppenheimerFunds
New York
$15.2M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$10.4M +$468K +15,427 +5%
BFA
6
BlackRock Fund Advisors
California
$10.2M +$3.33M +109,991 +48%
BIT
7
BlackRock Institutional Trust
California
$10.1M +$197K +6,504 +2%
NMC
8
NEA Management Company
Maryland
$9.83M – – –
BC
9
Broadfin Capital
New York
$9.47M -$6.06M -200,000 -39%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$7.39M +$444K +14,650 +6%
DM
11
Deerfield Management
New York
$7.27M – – –
Millennium Management
12
Millennium Management
New York
$6.2M +$1.12M +36,816 +22%
Axa
13
Axa
France
$5.86M -$123K -4,067 -2%
UBS AM
14
UBS AM
Illinois
$5.29M -$634K -20,916 -11%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$4.91M -$619K -20,404 -11%
SAM
16
Senzar Asset Management
New York
$4.59M +$418K +13,791 +10%
State Street
17
State Street
Massachusetts
$4.36M +$9.28K +306 +0.2%
TC
18
TFS Capital
Pennsylvania
$3.79M -$843K -27,819 -18%
DCM
19
DAFNA Capital Management
California
$3.36M – – –
RSCM
20
Rock Springs Capital Management
Maryland
$3.33M +$3.34M +110,000 New
Northern Trust
21
Northern Trust
Illinois
$2.86M +$100K +3,299 +4%
NI
22
Numeric Investors
Massachusetts
$2.69M +$561K +18,489 +26%
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$2.67M – – –
RPAM
24
Rhenman & Partners Asset Management
Sweden
$2.56M -$245K -8,069 -9%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$2.27M -$35.6K -1,175 -2%
1
2 3 4 5

RIGL Hedge Fund Activity: Q4 2015 in Review

121 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2015, worth a combined $248M — up 26% from $197M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RIGL and 9 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 49 added.

The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $3.34M. The largest seller was Broadfin Capital, cutting an estimated $6.06M.

  • 121 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2015, down from 122 in Q3 2015.
  • Funds reported $248M of Rigel Pharmaceuticals stock for Q4 2015, up 26% quarter-over-quarter.
  • 9 funds opened new Rigel Pharmaceuticals positions in Q4 2015 and 10 closed out, a net change of -1 holder.
  • The largest Rigel Pharmaceuticals buyer in Q4 2015 was Rock Springs Capital Management, an estimated $3.34M added.
  • The largest Rigel Pharmaceuticals seller in Q4 2015 was Broadfin Capital, an estimated $6.06M sold.

Based on aggregated 13F filings for Q4 2015.